KLP Kapitalforvaltning’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.6M Buy
110,158
+7,000
+7% +$2.6M 0.14% 130
2026
Q1
$30.2M Buy
103,158
+240
+0.2% +$78.9K 0.12% 164
2025
Q4
$36.1M Buy
102,918
+17,240
+20% +$5.83M 0.14% 133
2025
Q3
$27.7M Hold
85,678
0.11% 179
2025
Q2
$33.3M Buy
85,678
+3,300
+4% +$1.33M 0.14% 138
2025
Q1
$35.8M Buy
82,378
+800
+1% +$321K 0.18% 111
2024
Q4
$30.1M Buy
+81,578
New +$34.1M 0.14% 133

Other funds holding ELV

KLP Kapitalforvaltning's ELV Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Elevance Health (ELV) stake by 6.8% in Q2 2026, buying an estimated $2.6M and bringing the position to 110,158 shares worth $42.6M. The position accounts for 0.14% of the portfolio, ranked #130.

KLP Kapitalforvaltning first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • KLP Kapitalforvaltning held 110,158 shares of Elevance Health worth $42.6M as of Q2 2026.
  • KLP Kapitalforvaltning bought 7,000 Elevance Health shares in Q2 2026, an estimated $2.6M.
  • Elevance Health made up 0.14% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #130 holding.
  • KLP Kapitalforvaltning first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.